Genetic Engineering & Biotechnology News

What Genetic Engineering & Biotechnology News does

Genetic Engineering & Biotechnology News (GEN) is a privately held, for-profit trade publication founded in 1981 and published by Mary Ann Liebert, Inc., with distribution operated under parent conglomerate Sage Publications. Headquartered in New Rochelle, New York, with a 51-100 person staff led by CEO Mary Ann Liebert, the company targets life sciences professionals — researchers, executives, lab managers, clinical researchers, business development personnel, and students — across eight topic areas spanning drug discovery, bioprocessing, omics, diagnostics, and translational medicine.

GEN operates a multi-channel media platform. Its core product is a print and digital magazine published 12 times per year, supported by a news website, seven eNewsletters (including a dedicated AI in Biotech Newsletter), podcasts (Touching Base, GENcast), webinars, virtual and in-person summits, GEN Live shows, Learning Labs, A-Lists, and eBooks. It also publishes two peer-reviewed journals — GEN Biotechnology and Re:Gen Open — extending the brand into scholarly publishing. The editorial team comprises seven senior editors (John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman, Fay Lin).

The business model is primarily B2B advertising and sponsorship supported by free magazine subscriptions, supplemented by revenue from sponsored webinars, summits, and Learning Labs, and from licensing/operations of the peer-reviewed journal line. Distribution to advertisers and contributors is amplified by the Sage Publications parent ecosystem, which provides scale in publishing operations and audience reach.

Name

Genetic Engineering & Biotechnology News

Legal name

Mary Ann Liebert, Inc.

Website

https://genengnews.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

51–100 employees

Short description

Genetic Engineering & Biotechnology News (GEN) is a 1981-founded B2B trade publication serving life sciences professionals with a multi-channel platform spanning a 12x/year magazine, seven eNewsletters, podcasts, webinars, summits, and two peer-reviewed journals, monetized primarily through advertising and sponsorships under publisher Mary Ann Liebert and parent Sage Publications.

Ownership category

akta.pro rank

Product category

Scientific Trade Media

NAICS

Periodical Publishers (513120), Periodical Publishers (51312), Book Publishers (513130)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Science, Technology & Gaming Magazines (MPAJAEAL)

akta.pro secondary industries

Academic & Scholarly Journals Publishing (Peer-Reviewed) (MPAJABAC), Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing (EDAGAFAC)

Keywords

• Biotech news media
• Life sciences publishing
• Scientific trade publications
• Biotechnology journalism
• Life science media

Headquarters

HQ city

New Rochelle

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Magazine Subscriptions: Free magazine subscription distributed 12 times per year in print and digital formats. Revenue is generated through advertising and sponsored content within the publication.
2. eNewsletters: Multiple newsletter offerings including GEN Daily & Weekly, AI in Biotech Newsletter, NextGEN Bioprocessing, GEN Product Insider, GEN Tech Focus, GEN Webinars eBooks & Live Events, and GEN Podcasts. Delivered to subscribed professionals in the life sciences industry.
3. Advertising and Sponsorship: Digital advertising on the website and sponsored content opportunities including webinars, summits, and multimedia content. The company also offers media kits and planning calendars for advertisers.
4. Peer-Reviewed Journals: Publishing peer-reviewed journals including GEN Biotechnology and Re:Gen Open through partnership with Mary Ann Liebert, Inc.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

GEN publishes a print and digital magazine covering genetic engineering and biotechnology news, distributed 12 times per year to qualified life sciences subscribers, alongside a suite of digital content products. The media portfolio includes seven email newsletter variants, two peer-reviewed journals (GEN Biotechnology and Re:Gen Open), and multimedia extensions including podcasts, webinars, summits, GEN Live shows, and Learning Labs covering AI, Bioprocessing, Cancer, Drug Discovery, Genome Editing, Infectious Diseases, OMICs, and Translational Medicine. Revenue is primarily generated through advertising, sponsored content, and journal subscriptions.

Product overview

GEN (Genetic Engineering & Biotechnology News) is a unified media platform offering a print and digital magazine alongside a suite of digital content products. The core offering is GEN Magazine (12x/year), supplemented by GEN eNewsletters (7 variants), the GEN Edge sub-brand for premium content, and multimedia products including Touching Base and GENcast podcasts, Webinars, Summits, GEN Live shows, and Learning Labs. Additional resources include A-Lists (industry rankings), eBooks, New Products announcements, and topic-specific content sections covering AI, Bioprocessing, Cancer, Drug Discovery, Genome Editing, Infectious Diseases, OMICs, and Translational Medicine. The portfolio is organized around a news and insights model with multimedia extensions.

Differentiator

Problem solved

Functional benefit

Brands

• GEN Edge: A section of the publication focusing on breaking news and analysis in biotechnology.
• Touching Base
• GENcast

Products and services

• GEN Magazine Print and digital magazine covering genetic engineering and biotechnology news, published 12 times per year and distributed free to qualified subscribers in the life sciences industry. Available in Print & Digital or Digital-only versions.
• GEN eNewsletters Suite of seven email newsletters delivered to qualified life sciences professionals, including GEN Daily & Weekly, AI in Biotech Newsletter, NextGEN Bioprocessing, GEN Product Insider, GEN Tech Focus, GEN Webinars eBooks & Live Events, and GEN Podcasts.
• GEN Biotechnology Peer-reviewed biotechnology journal published through partnership with Mary Ann Liebert, Inc. at home.liebertpub.com, covering biotechnology and life sciences research.
• Re:Gen Open Peer-reviewed open-access journal published through partnership with Mary Ann Liebert, Inc. covering biotechnology and regenerative medicine research.
• Webinars On-demand and live educational webinars covering biotechnology topics such as AAV analytics, cell phenotyping, CRISPR screening, bioprocessing, and monoclonal antibody processing, sponsored by life sciences companies.
• Summits Virtual summits covering state-of-industry topics including Multiomics & NGS, Cell and Gene Therapy, AI in Drug Discovery, CRISPR & Genome Editing, and broader Biotech themes.
• Touching Base Podcast Dynamic podcast series featuring rotating senior editors discussing emerging stories, trends, and leading voices in biotech.
• GENcast Podcast series covering topics in genetic engineering and biotechnology, including in vivo lentiviral therapies, manufacturing strategies, and biotech industry updates.

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves1 record

Expansion highlights5 records

Peers

• STAT News:

Direct peers

• Endpoints News: Digital-native daily biotech news outlet covering drug development, deal flow, and industry executives. Directly competes with GEN for biotech executive readership and pharma/biotech advertising dollars.
• Fierce Biotech: Long-standing B2B biotech trade publication covering pharma R&D, clinical trials, and industry news with newsletter and website distribution. Closely comparable to GEN in audience (biotech professionals) and advertising-driven model.
• BioSpace: Life sciences news, job board, and industry resource platform serving biotech professionals. Competes with GEN for biotech audience attention, advertising revenue, and talent/community engagement.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/GENbio
• YouTubeyoutube.com/gennews
• Facebookfacebook.com/gennews
• LinkedInlinkedin.com/company/1385856

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetic Engineering & Biotechnology News